Corient Private Wealth’s Rapport Therapeutics RAPP Stock Holding History
Bought
Maintained
Sold
Other funds holding RAPP
Corient Private Wealth's RAPP Position: Q3 2026 in Review
Corient Private Wealth opened a new position in Rapport Therapeutics (RAPP) in Q3 2026: 15,499 shares worth $521K. The stake represents ﹤0.01% of the portfolio and ranks #2434 among its holdings.
169 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.
- Corient Private Wealth held 15,499 shares of Rapport Therapeutics worth $521K as of Q3 2026.
- Rapport Therapeutics was a new Corient Private Wealth position in Q3 2026.
- Rapport Therapeutics made up ﹤0.01% of Corient Private Wealth's portfolio in Q3 2026, its #2434 holding.
- 169 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.
Based on Corient Private Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.